SEC filing summary: General Enterprise Ventures, Inc. (GEVI)
Entity note: The supplied filing is for General Enterprise Ventures, Inc., not Citrotech Inc. The company reports that it acquired Mighty Fire Breaker, LLC, whose CitroTech-branded fire-prevention products are central to its business. This is a Form 10-K for the year ended December 31, 2022, filed March 31, 2023; it is not a standalone fourth-quarter report.
Business context and reporting period
GEVI describes itself as a technology company focused on developing and acquiring emerging technologies. In April 2022, it acquired MFB and its related intellectual property for 1,000,000 Series C preferred shares, valued at $4.2 million, and agreed to pay the seller a 10% royalty on pre-tax gross sales of MFB products. MFB reports 19 patents related to wildfire prevention. The company says its products received EPA Safer Choice status and UL GreenGuard Gold approval in Q3 2022, with further testing and accreditations being pursued.
Effective April 1, 2022, GEVI began divesting its cryptocurrency-mining operations to concentrate resources on MFB. It formed a UK subsidiary in November to support sales in Europe, the Middle East and Africa. The company reports eight full-time employees.
Financial performance and liquidity
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Revenue from continuing operations, per financial statements | $62,732 | $0 |
| Gross profit | $60,839 | $20,306, including cryptocurrency-mining revenue |
| Operating expenses | $2,979,398 | $58,213 |
| Loss from continuing operations | $(2,918,814) | $(44,973) |
| Net loss | $(2,907,828) | $(94,973) |
| Cash used in operating activities | $(708,450) | $(24,206) |
| Cash at year-end | $55,434 | $5,469 |
| Working capital (deficiency) | $(890,839) | $(377,621) |
Operating expenses included $2.1 million in non-cash stock-based compensation for a 70-million-share restricted award to the CEO, $500,875 in professional fees and $377,720 in general and administrative expense. The reported gross margin on continuing-operation revenue was approximately 97%, before operating expenses.
At year-end, current assets were $170,079 and current liabilities were $1,060,918. Current liabilities included $899,153 due to related parties, a $35,000 convertible note, $87,398 in accounts payable and accrued liabilities, and $39,367 in current lease liability. Total assets were $4,409,586, including $4,195,353 of acquired intangible assets; total liabilities were $1,060,918. Financing provided $763,764 of cash in 2022, primarily through related-party advances.
The filing contains a revenue discrepancy: the financial statements report $62,732 of 2022 continuing revenue, while the MD&A narrative says $67,732. Separately, the discontinued-operations note reports $46,976 of cryptocurrency-mining revenue through the April 2022 divestiture. The filing does not clearly reconcile these presentations.
Changes versus the prior year
- Revenue from continuing operations rose from zero to $62,732, but operating expenses increased by approximately $2.92 million, principally reflecting the CEO stock award, professional fees and general and administrative costs.
- Net loss widened to $2.91 million from $94,973. The $2.1 million stock award was non-cash.
- Cash rose by $49,965, but operating cash outflow increased substantially and the working-capital deficit expanded by $513,218.
- GEVI acquired MFB, recorded $4.20 million of preferred-stock consideration and $4.20 million of related intangible assets, and discontinued crypto mining.
- Common shares outstanding increased to 93,945,388 from 22,945,388. The CEO award accounts for 70 million restricted shares, subject to release conditions described in the filing.
Outlook, risks and unusual items
- Outlook: No quantified revenue or earnings guidance is provided. Management says it is focusing resources on MFB and pursuing further product accreditations, including testing relevant to government sales. Its ability to continue as a going concern depends on raising capital and generating revenue and profits.
- Going concern: Management and the auditor state that significant operating losses and limited operating capital raise substantial doubt about the company’s ability to continue as a going concern. The audited statements include no adjustments for a possible failure to continue.
- Concentration and execution: The business is transitioning to MFB, with limited reported revenue to date; the acquired intellectual property represents most of total assets. Product testing, customer adoption, regulatory approvals and commercialization remain important execution factors.
- Related parties and dilution: Related-party balances and advances are material. The MFB seller royalty is 10% of pre-tax gross product sales. Series C preferred shares convert at 20 common shares per preferred share; Series A preferred shares carry 1,000 votes and conversion shares per preferred share. The CEO’s 70 million restricted shares carry voting rights and are subject to annual gross-revenue targets of at least $100 million for each of 2023–2026 for release.
- Controls and governance: Management reported ineffective disclosure controls and a material weakness involving lack of segregation of duties and formal financial-close review procedures. The control evaluation text refers to December 31, 2021, while the filing is for 2022; it also states no material control changes during 2022. The board has no independent directors or standing committees.
- Market and other risks: The common stock trades thinly on OTC Pink, and the company says there is no assurance a liquid market will develop. Cited risks include third-party service disruptions, supply-chain or commodity cost increases, pandemics and tax-rate changes. No material legal proceedings or off-balance-sheet arrangements were reported.
The independent auditor issued an unmodified opinion on the financial statements and highlighted the going-concern uncertainty; it reported no critical audit matters. The filing reports no audit fees billed for 2022, compared with $28,500 for 2021.
Important facts for investors to verify
- Confirm the correct issuer: the filing is for General Enterprise Ventures, Inc. (GEVI), not Citrotech Inc.
- Reconcile the $62,732 financial-statement revenue with the $67,732 MD&A figure and clarify how discontinued crypto-mining revenue is presented.
- Review the company’s near-term funding needs, repayment terms and related-party balances, and the basis for management’s going-concern assessment.
- Verify MFB sales traction, product testing and approvals, the 10% royalty terms, and whether the $100 million annual revenue conditions for the CEO’s restricted shares are attainable.
- Assess potential dilution and voting control from preferred-stock conversion rights, the restricted share award and outstanding share counts.
- Check remediation progress for the reported internal-control weakness and clarify the year referenced in management’s control-effectiveness evaluation.